{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-003718","form_type":"8-K","ticker":"ANEB","cik":"0001815974","company_name":"Anebulo Pharmaceuticals, Inc.","filed_at":"2026-01-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.280167+00:00","generated_at":"2026-05-16T07:35:12.822134+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Anebulo tender offer oversubscribed; 4.9M shares tendered, 300k accepted at $3.50 per share","bullets":["4,897,188 shares properly tendered (excluding 10,868 by guaranteed delivery).","Company expects to accept 300,000 shares at $3.50 each for total cost of ~$1.05M.","Proration factor approximately 3.51542%; odd lots accepted in full.","Shares accepted represent about 0.73% of outstanding as of Jan 26, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-003718","json":"https://secwatch.observer/filing/0001493152-26-003718.json","markdown":"https://secwatch.observer/filing/0001493152-26-003718.md","text":"https://secwatch.observer/filing/0001493152-26-003718.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815974/000149315226003718/0001493152-26-003718-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815974/000149315226003718/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T07:35:12.822134+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}